Sökning: id:"swepub:oai:lup.lub.lu.se:dc8f4da4-888b-489c-a035-87abca423635" >
Expression of Id pr...
-
Ahlqvist, KristoferLund University,Lunds universitet,Institutionen för translationell medicin,Medicinska fakulteten,Department of Translational Medicine,Faculty of Medicine
(författare)
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
- Artikel/kapitelEngelska2013
Förlag, utgivningsår, omfång ...
-
2012-05-14
-
Springer Science and Business Media LLC,2013
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:dc8f4da4-888b-489c-a035-87abca423635
-
https://lup.lub.lu.se/record/2608873URI
-
https://doi.org/10.1038/onc.2012.175DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
B-cell leukemia 3 (Bcl-3) is a member of the inhibitor of κB family, which regulates a wide range of biological processes by functioning as a transcriptional activator or as a repressor of target genes. As high levels of Bcl-3 expression and activation have been detected in different types of human cancer, Bcl-3 has been labeled a proto-oncogene. Our study uncovered a markedly upregulated Bcl-3 expression in human prostate cancer (PCa), where inflammatory cell infiltration was observed. Elevated Bcl-3 expression in PCa was dependent on the proinflammatory cytokine interleukin-6-mediated STAT3 activation. Microarray analyses, using Bcl-3 knockdown in PCa cells, identified the inhibitor of DNA-binding (Id) family of helix-loop-helix proteins as potential Bcl-3-regulated genes. Bcl-3 knockdown reduced the abundance of Id-1 and Id-2 proteins and boosted PCa cells to be more receptive to undergoing apoptosis following treatment with anticancer drug. Our data imply that inactivation of Bcl-3 may lead to sensitization of cancer cells to chemotherapeutic drug-induced apoptosis, thus suggesting a potential therapeutic strategy in PCa treatment.Oncogene advance online publication, 14 May 2012; doi:10.1038/onc.2012.175.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Saamarthy, KarunakarLund University,Lunds universitet,Institutionen för translationell medicin,Medicinska fakulteten,Department of Translational Medicine,Faculty of Medicine(Swepub:lu)med-kus
(författare)
-
Syed Khaja, A S
(författare)
-
Bjartell, AndersLund University,Lunds universitet,Institutionen för translationell medicin,Medicinska fakulteten,Department of Translational Medicine,Faculty of Medicine(Swepub:lu)kir-abj
(författare)
-
Massoumi, RaminLund University,Lunds universitet,Institutionen för translationell medicin,Medicinska fakulteten,Department of Translational Medicine,Faculty of Medicine(Swepub:lu)expp-rma
(författare)
-
Institutionen för translationell medicinMedicinska fakulteten
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Oncogene: Springer Science and Business Media LLC32:12, s. 1601-16081476-55940950-9232
Internetlänk
Hitta via bibliotek
-
Oncogene
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas